According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

This pharmaceutical giant is increasingly looking unstoppable.

The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That ...

A claim has emerged that the pharmaceutical and bio-pharma industry could suffer annual losses of up to 3.6 trillion won if a policy to reduce generic drug prices to 40% of original drug prices is ...

Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the University of Connecticut back to the pod to the current state of drug prices, how ...

Our Bureau, Bengaluru Wednesday, February 4, 2026, 12:40 Hrs [IST] ...

The Union Budget's focus on biopharma is poised to enhance India's pharmaceutical innovation and research capabilities ...

“Affordability” is the watchword in American politics today. Inflation is squeezing families, but nothing hits harder than the cost of trying to stay alive. Yet as patients weigh whether they can ...